Omega Fund Management, LLC - ATEA PHARMACEUTICALS INC ownership

ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 82 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.60 and the average weighting 1.9%.

Quarter-by-quarter ownership
Omega Fund Management, LLC ownership history of ATEA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$5,770,000
-64.0%
164,577
-78.0%
0.65%
-64.4%
Q2 2021$16,043,000
-69.3%
746,868
-11.8%
1.82%
-63.3%
Q1 2021$52,315,000
+47.8%
847,2080.0%4.95%
-6.8%
Q4 2020$35,396,000847,2085.31%
Other shareholders
ATEA PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Tyrus Capital S.A.M. 1,260,000$3,780,00035.90%
BML Capital Management, LLC 4,800,000$14,400,00013.22%
Stonepine Capital Management, LLC 1,720,000$5,160,0001.71%
TANG CAPITAL MANAGEMENT LLC 3,600,000$10,800,0001.52%
CM Management, LLC 275,000$825,0000.88%
Bain Capital Life Sciences Investors, LLC 2,485,638$7,456,9140.83%
EcoR1 Capital, LLC 6,995,861$20,987,5830.71%
SECTORAL ASSET MANAGEMENT INC 600,461$1,801,3830.35%
Newtyn Management, LLC 400,000$1,200,0000.30%
Diametric Capital, LP 200,000$600,0000.25%
View complete list of ATEA PHARMACEUTICALS INC shareholders